OpenAlex
PricingAboutJobs
Log inGet started
Work

Cardiovascular and heart failure safety profile of vildagliptin: a meta‐analysis of 17 000 patients

HTML

Year: 2015
Type: review
Study designs: Systematic Review, Meta-Analysis
Source: Diabetes Obesity and Metabolism
DOI: 10.1111/dom.12548
Authors: G. McInnes, M. Evans, S. Del Prato, M. Stumvoll, A. Schweizer, V. Lukashevich, Q. Shao, W. Kothny
Institutions: University of Glasgow, University Hospital Llandough, University of Pisa, University Hospital Leipzig, Novartis (Switzerland), Novartis (United States)
Language: English

Topic: Diabetes Treatment and Management
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Keywords: vildagliptin, cardiovascular safety, heart failure risk, major adverse cardiovascular events, type 2 diabetes, GLP-1 receptor agonists, congestive heart failure, renal dysfunction, myocardial infarction, stroke, cardiovascular mortality, heart failure hospitalization, drug safety, high-risk patients, relative risk, DPP-4 inhibitors
SDG: Good health and well-being

Open Access status: closed

Funders: Bristol-Myers Squibb, Eli Lilly and Company, Merck Sharp and Dohme
OpenAlex ID: W1846464686
FWCI: 2.131
Cites: 63
Cited by: 117
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Subscribe
Supporters
Legal
Privacy
Accessibility
Terms
Security